ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P-114 A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma
Annals of Oncology
◽
10.1093/annonc/mdv233.114
◽
2015
◽
Vol 26
◽
pp. iv32
Author(s):
A. Kaseb
◽
H. Al-Shamsi
◽
J. Morris
◽
M. Iwasaki
◽
L. Xiao
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.4088
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 4088-4088
Author(s):
Ahmed Omar Kaseb
◽
Humaid Obaid Al-Shamsi
◽
Jeffrey Morris
◽
Michiko Iwasaki
◽
Lianchun Xiao
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
OncoTargets and Therapy
◽
10.2147/ott.s91977
◽
2016
◽
pp. 773
◽
Cited By ~ 10
Author(s):
Ahmed Kaseb
◽
Jeffrey Morris
◽
Michiko Iwasaki
◽
Humaid Al-Shamsi
◽
Kanwal Raghav
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study
European Journal of Cancer
◽
10.1016/j.ejca.2013.05.028
◽
2013
◽
Vol 49
(16)
◽
pp. 3412-3419
◽
Cited By ~ 131
Author(s):
Jordi Bruix
◽
Won-Young Tak
◽
Antonio Gasbarrini
◽
Armando Santoro
◽
Massimo Colombo
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Open Label
◽
Second Line Therapy
◽
Safety Study
◽
Line Therapy
◽
Open Label Phase
Download Full-text
Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-11-1991
◽
2012
◽
Vol 18
(7)
◽
pp. 2090-2098
◽
Cited By ~ 105
Author(s):
Richard S. Finn
◽
Yoon-Koo Kang
◽
Mary Mulcahy
◽
Blase N. Polite
◽
Ho Yeong Lim
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Phase Ii
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Open Label
◽
Second Line Therapy
◽
Open Label Study
◽
Label Study
◽
Line Therapy
Download Full-text
Feasibility and benefits of systemic second-line therapy in advanced hepatocellular carcinoma (HCC) – a retrospective analysis
Zeitschrift für Gastroenterologie
◽
10.1055/s-0033-1360896
◽
2014
◽
Vol 52
(01)
◽
Author(s):
S Koch
◽
A Weinmann
◽
JU Marquardt
◽
PR Galle
◽
MA Wörns
Keyword(s):
Hepatocellular Carcinoma
◽
Retrospective Analysis
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial
Journal of Cancer
◽
10.7150/jca.37610
◽
2019
◽
Vol 10
(25)
◽
pp. 6185-6190
Author(s):
Seung Tae Kim
◽
Sung Yong Oh
◽
Jeeyun Lee
◽
Jung Hun Kang
◽
Hyun Woo Lee
◽
...
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Phase Ii Trial
◽
Second Line
◽
Open Label
◽
Second Line Therapy
◽
Biliary Tract Cancers
◽
Line Therapy
◽
Open Label Phase
Download Full-text
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer
Investigational New Drugs
◽
10.1007/s10637-005-0754-6
◽
2005
◽
Vol 23
(6)
◽
pp. 563-567
◽
Cited By ~ 6
Author(s):
Afshin Dowlati
◽
Robert Chapman
◽
Shanmuga Subbiah
◽
Pingfu Fu
◽
Anne Ness
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Second Line
◽
Small Cell Lung
◽
Second Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Eligibility for Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma
American Journal of Clinical Oncology
◽
10.1097/coc.0000000000000754
◽
2020
◽
Vol Publish Ahead of Print
◽
Author(s):
Erica S. Tsang
◽
Janine M. Davies
◽
Jonathan M. Loree
◽
Howard J. Lim
◽
Daniel J. Renouf
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States
BMC Gastroenterology
◽
10.1186/s12876-020-01241-y
◽
2020
◽
Vol 20
(1)
◽
Author(s):
Maximilian Sieg
◽
Michael Hartmann
◽
Utz Settmacher
◽
Habibollah Arefian
Keyword(s):
United States
◽
Hepatocellular Carcinoma
◽
Cost Effectiveness
◽
The United States
◽
Advanced Hepatocellular Carcinoma
◽
Second Line
◽
Second Line Therapy
◽
Comparative Cost
◽
Line Therapy
Download Full-text
Second Line Therapy with Sunitinib As Single Agent in Patients with Advanced Intrahepatic Cholangiocarcinoma (Update on Sun-Ck Phase Ii Trial)
Annals of Oncology
◽
10.1093/annonc/mdu334.105
◽
2014
◽
Vol 25
◽
pp. iv244
Author(s):
C. Neuzillet
◽
J. Seitz
◽
L. Fartoux
◽
D. Malka
◽
G. Lledo
◽
...
Keyword(s):
Phase Ii
◽
Intrahepatic Cholangiocarcinoma
◽
Phase Ii Trial
◽
Single Agent
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close